SIA
TGTX icon

Sit Investment Associates’s TG Therapeutics TGTX Stock Holding History

Sit Investment Associates’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13M Hold
20,480
– – 0.02% 357
2026
Q1 		$680K Hold
20,480
– – 0.01% 396
2025
Q4 		$611K Hold
20,480
– – 0.01% 406
2025
Q3 		$740K Buy
+20,480
New +$675K 0.02% 389

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

Sit Investment Associates's TGTX Position: Q2 2026 in Review

Sit Investment Associates held its TG Therapeutics (TGTX) position steady in Q2 2026 at 20,480 shares worth $1.13M. The position accounts for 0.02% of the portfolio, ranked #357.

Sit Investment Associates first reported a position in TGTX in Q3 2025 and has held it in 4 quarters since. 431 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Sit Investment Associates held 20,480 shares of TG Therapeutics worth $1.13M as of Q2 2026.
  • Sit Investment Associates left its TG Therapeutics share count unchanged in Q2 2026.
  • TG Therapeutics made up 0.02% of Sit Investment Associates's portfolio in Q2 2026, its #357 holding.
  • Sit Investment Associates first reported a position in TG Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 431 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Sit Investment Associates's 13F filing for Q2 2026, filed 12 Aug 2026.